non
on 15 Oct 2024
Last Applicant/ Owned by
46701 Commerce Center Drive
Plymouth
MI
48170
Serial Number
97091070 filed on 25th Oct 2021
Registration Number
N/A
Correspondent Address
ROGER H. BORA
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of blood samples for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of blood samples for Read More
Scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of blood samples for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of blood samples for the purpose of improving quality in the field of healthcare services, specifically for improving the monitoring and diagnostics of quantitative patient drug exposure, the monitoring and diagnostics of patient drug compliance, data-driven analytics and reporting to providers of healthcare services in the field of pharmacovigilance activities, drug dosage recommendations, initial drug prescribing, and drug switching, all for research purposes and not for medical purposes; genetic testing for scientific research purposes, specifically pharmacogenomic testing, analysis, and evaluation of buccal, saliva and other biological samples for the purposes of analyzing how the genetic makeup of an individual affects their response to drugs, improving drug selection and dosage recommendations, selecting initial and subsequent medications, identifying drug-drug interactions, avoiding adverse drug reactions, developing clinical treatment decision support recommendations, and supporting other medical diagnostic products and prescription drugs; genetic testing for scientific research purposes, namely, analysis of multiple genes and genetic variants and their effect on drug response across multiple therapeutic areas, including but not limited to psychiatry, pain, cardiology, and oncology; scientific and technological services in the field of pharmaceuticals in the nature of scientific testing, analysis and evaluation of biological samples for research purposes, specifically research in the field of clinical trials, and research in the field of new drug development and drug repurposing
31st Jan 2023
31st Jan 2023
No 97091070
No Service Mark
No 101369-004
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
15th Oct 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
15th Oct 2024 | NON-FINAL ACTION E-MAILED |
15th Oct 2024 | SU - NON-FINAL ACTION - WRITTEN |
15th Jun 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
15th Jun 2024 | STATEMENT OF USE PROCESSING COMPLETE |
13th May 2024 | TEAS STATEMENT OF USE RECEIVED |
13th May 2024 | USE AMENDMENT FILED |
11th May 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
10th May 2024 | SOU EXTENSION 1 GRANTED |
10th May 2024 | SOU EXTENSION 1 FILED |